• Episode 24 - Amy Chesire & Greg Suter

  • May 28 2021
  • Duración: 52 m
  • Podcast

Episode 24 - Amy Chesire & Greg Suter Por arte de portada

Episode 24 - Amy Chesire & Greg Suter

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • Amy Chesire (University of Rochester) and Greg Suter (Hereditary Neurological Disease Centre) are long-time site coordinators for clinical trials in Huntington's disease. On this episode of the HD Insights Podcast, we spoke with both about their history of working with clinical study participants and their current experience with participants on the KINECT-HD study.

    KINECT-HD is a Phase 3, randomized, double-blind, placebo-controlled study investigating valbenazine for treatment of chorea in Huntington disease. The study is being conducted at sites across the U.S. and Canada. Additional information about the study can be found at www.KINECT-HD.org.

    Más Menos
Ciencia
Más Menos

Lo que los oyentes dicen sobre Episode 24 - Amy Chesire & Greg Suter

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles